Table I Index
Table of Contents
Table I - 71 St. Joseph Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
Number | Rate | Number | Rate | Number | Rate | |
All sites | 1,230 | 390.6 | 611 | 451.9 | 619 | 355.3 |
Oral cavity and pharynx | 35 | 11.7 | 22 | 17.4 | 13 | 7.0** |
Lip | * | # | * | # | * | # |
Tongue | 8 | 2.6** | * | # | 5 | 2.7** |
Major salivary glands | 7 | 2.4** | * | # | * | # |
Floor of mouth | * | # | * | # | * | # |
Gum and other mouth | 9 | 2.9** | 6 | 4.6** | * | # |
Nasopharynx | * | # | * | # | * | # |
Tonsil | * | # | * | # | * | # |
Oropharynx | * | # | * | # | * | # |
Hypopharynx | * | # | * | # | * | # |
Pharynx and other oral cavity | * | # | * | # | * | # |
Digestive system | 231 | 68.8 | 128 | 92.2 | 103 | 53.7 |
Esophagus | 14 | 4.1** | 11 | 7.8** | * | # |
Stomach | 17 | 5.2** | 7 | 5.4** | 10 | 5.3** |
Small intestine | 7 | 2.1** | * | # | 5 | 2.9** |
Colon excluding rectum | 114 | 33.1 | 62 | 44.3 | 52 | 25.8 |
Rectum and rectosigmoid | 38 | 11.9 | 22 | 15.8 | 16 | 9.2** |
Anus, anal canal, and anorectum | * | # | * | # | * | # |
Liver and intrahepatic bile duct | 8 | 2.8** | 6 | 4.5** | * | # |
Gallbladder | * | # | * | # | * | # |
Other biliary | 5 | 1.5** | * | # | * | # |
Pancreas | 24 | 7.0 | 13 | 9.6** | 11 | 5.3** |
Retroperitoneum | * | # | * | # | * | # |
Peritoneum | * | # | * | # | * | # |
Other digestive organs | * | # | * | # | * | # |
Respiratory system | 208 | 67.3 | 124 | 91.8 | 84 | 50.1 |
Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
Larynx | 11 | 3.7** | 8 | 6.2** | * | # |
Lung and bronchus | 194 | 62.7 | 113 | 83.5 | 81 | 48.3 |
Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
Bones and joints | * | # | * | # | * | # |
Soft tissue (including heart) | 9 | 2.6** | 7 | 5.1** | * | # |
Skin (excluding basal and squamous) | 30 | 9.6 | 16 | 11.2** | 14 | 8.7** |
Melanoma of the skin | 30 | 9.6 | 16 | 11.2** | 14 | 8.7** |
Other non-epithelial skin cancers | * | # | * | # | * | # |
Breast | 199 | 63.8 | * | # | 199 | 115.2 |
Female genital system | 102 | 34.6 | -- | -- | 102 | 64.1 |
Cervix uteri | 14 | 4.5** | -- | -- | 14 | 8.5** |
Corpus uteri | 44 | 15.6 | -- | -- | 44 | 28.8 |
Uterus, NOS | * | # | -- | -- | * | # |
Ovary | 38 | 12.6 | -- | -- | 38 | 23.3 |
Vagina | * | # | -- | -- | * | # |
Vulva | 5 | 1.4** | -- | -- | 5 | 2.5** |
Other female genital organs | * | # | -- | -- | * | # |
Male genital system | 172 | 54.9 | 172 | 127.7 | -- | -- |
Prostate gland | 160 | 51.2 | 160 | 119.8 | -- | -- |
Testis | 10 | 3.0** | 10 | 6.5** | -- | -- |
Penis | * | # | * | # | -- | -- |
Other male genital organs | * | # | * | # | -- | -- |
Urinary system | 104 | 32.5 | 79 | 58.5 | 25 | 14.5 |
Urinary bladder | 65 | 19.6 | 52 | 38.2 | 13 | 7.1** |
Kidney and renal pelvis | 33 | 11.2 | 24 | 18.3 | 9 | 5.9** |
Ureter | 5 | 1.5** | * | # | * | # |
Other urinary organs | * | # | * | # | * | # |
Eye and orbit | * | # | * | # | * | # |
Brain and other nervous system | 23 | 8.3 | 9 | 7.3** | 14 | 8.7** |
Brain | 22 | 7.9 | 9 | 7.3** | 13 | 8.0** |
Other nervous system | * | # | * | # | * | # |
Endocrine system | 10 | 3.1** | * | # | 10 | 5.9** |
Thyroid gland | 8 | 2.5** | * | # | 8 | 4.7** |
Other endocrine (including thymus) | * | # | * | # | * | # |
Lymphoma | 53 | 16.5 | 23 | 16.8 | 30 | 15.4 |
Hodgkin’s disease | 8 | 2.7** | * | # | 5 | 2.7** |
Non-Hodgkin’s lymphoma | 45 | 13.8 | 20 | 14.3 | 25 | 12.7 |
Multiple myeloma | 9 | 2.7** | 7 | 5.4** | * | # |
Leukemia | 19 | 6.2** | 10 | 7.6** | 9 | 4.9** |
Acute lymphocytic | * | # | * | # | * | # |
Chronic lymphocytic | 7 | 2.1** | * | # | * | # |
Acute myeloid | 5 | 1.7** | * | # | * | # |
Chronic myeloid | * | # | * | # | * | # |
Other leukemias | * | # | * | # | * | # |
Other, ill-defined and unknown sites | 24 | 7.5 | 13 | 10.3** | 11 | 5.3** |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |